PT - JOURNAL ARTICLE AU - Karlsson, Ida K. AU - Zhan, Yiqiang AU - Wang, Yunzhang AU - Li, Xia AU - Jylhävlä, Juulia AU - Hägg, Sara AU - Aslan, Anna K. Dahl AU - Gatz, Margaret AU - Pedersen, Nancy L. AU - Reynolds, Chandra A. TI - Adiposity and the risk of dementia: mediating effects from inflammation and lipid levels AID - 10.1101/2022.03.03.22271843 DP - 2022 Jan 01 TA - medRxiv PG - 2022.03.03.22271843 4099 - http://medrxiv.org/content/early/2022/03/05/2022.03.03.22271843.short 4100 - http://medrxiv.org/content/early/2022/03/05/2022.03.03.22271843.full AB - Objective While midlife adiposity is a risk factor for dementia, adiposity in late-life appears to be associated with lower risk. What drives the associations is poorly understood, especially the inverse association in late-life.Methods Using results from genome-wide association studies, we identified inflammation and lipid metabolism as biological pathways involved in both adiposity and dementia. To test if these factors mediate the effect of midlife and/or late-life adiposity on dementia, we then used cohort data from the Swedish Twin Registry, with measures of adiposity and potential mediators taken in midlife (age 40-64, n=5999) or late-life (age 65-90, n=7257). Associations between body-mass index (BMI), waist-hip ratio (WHR), C-reactive protein (CRP), lipid levels, and dementia were tested in survival and mediation analyses.Results One standard deviation (SD) higher WHR in midlife was associated with 25% (95% CI 2-52%) higher dementia risk, with slight attenuation when adjusting for BMI. No evidence of mediation through CRP or lipid levels was present. After age 65, one SD higher BMI, but not WHR, was associated with 8% (95% CI 1-14%) lower dementia risk. The association was partly mediated by higher CRP and suppressed by lower high-density lipoprotein.Interpretation The negative effects of midlife adiposity on dementia risk were driven directly by factors associated with body fat distribution, and not mediated by inflammation or lipid levels. There was an inverse association between late-life adiposity and dementia risk, especially where the body’s inflammatory response and lipid homeostasis is intact.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Strategic Research Program in Epidemiology at Karolinska Institutet; the Swedish Research Council for Health, Working Life and Welfare (2018-01201); the Swedish Research Council (2016-03081); and the National Institutes of Health (R01 AG060470). We acknowledge the Swedish Twin Registry for access to data. The Swedish Twin Registry is managed by Karolinska Institutet and receives funding through the Swedish Research Council under the grant no. 2017-00641. The STR sub-studies were supported by the National Institutes of Health (grants R01 AG10175, R01 AG08724, R01 AG08861, R01 AG028555, and U01 DK066134), the MacArthur Foundation Research Network on Successful Aging, the Axel and Margaret Ax:son Johnsons Foundation, the Swedish Research Council, the Swedish Foundation for Health Care Sciences and Allergy Research, and the Swedish Council for Working Life and Social Research (2013-2292).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Regional Ethical Review Board in StockholmI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data are held by the Swedish Twin Registry, and can be applied for through the link below. Codes, logs, and outputs are available on: https://github.com/ik-karlsson/Adiposity_dementia_mediation https://ki.se/en/research/swedish-twin-registry-for-researchers